Ara
Toplam kayıt 11, listelenen: 1-10
Can Megestrol Acetate Induce Thrombosis in Advanced Oncology Patients Receiving Chemotherapy?
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: Megestrol acetate (MA) is a steroid origin medicine often used for control of cachexia in oncologic palliative care. Thrombosis is a common problem in oncology patients. One question is whether MA can cause ...
Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?
(LIPPINCOTT WILLIAMS & WILKINS, 2014)
The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic ...
Stereotactic Vacuum-Assisted Core Biopsy Results for Non-Palpable Breast Lesions
(ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)
Background: The increase in breast cancer awareness and widespread use of mammographic screening has led to an increased detection of (non-palpable) breast cancers that cannot be discovered through physical examination. ...
Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
(TERMEDIA PUBLISHING HOUSE LTD, 2016)
Aim of the study: Sunitinib-related side effects may develop as a result of the pharmacokinetic pathway affects the of the drug. Material and methods: Data on mRCC patients were obtained from the hospital archives. Outcomes ...
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
(SPANDIDOS PUBL LTD, 2015)
The aim of the present study was to identify the optimal Ki-67 cut-off value in breast cancer (BC) patients, and investigate the association of Ki-67 expression levels with other prognostic factors. Firstly, a retrospective ...
Current adjuvant treatment modalities for gastric cancer: From history to the future
(BAISHIDENG PUBLISHING GROUP INC, 2016)
The discrepancy between the surgical technique and the type of adjuvant chemotherapy used in clinical trials and patient outcomes in terms of overall survival rates has led to the generation of different adjuvant treatment ...
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase. study
(BAISHIDENG PUBLISHING GROUP INC, 2018)
AIM To evaluate the efficacy and tolerability of neoadjuvant hyperfractionated accelerated radiotherapy (HART) and concurrent chemotherapy in patients with locally advanced infraperitoneal rectal cancer. METHODS A total ...
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
(Mdpi, 2023)
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH levels are more sensitive ...
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
(Dove Medical Press Ltd, 2023)
Background: The minichromosome maintenance protein-2 (MCM-2) is a more sensitive proliferation marker than Ki-67. This study aimed to evaluate the relationship between MCM-2 and Oncotype DX recurrence score (ODX-RS) and ...
Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
(Frontiers Media Sa, 2023)
Background: The Oncotype Dx recurrence score (ODx-RS) guides the adjuvant chemotherapy decision-making process for patients with early-stage hormone receptor-positive, HER-2 receptor-negative breast cancer. This study aimed ...